VERA THERAPEUTICS INC's ticker is VERA and the CUSIP is 92337R101. A total of 86 filers reported holding VERA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $74,655,967 | -28.8% | 5,445,366 | -16.7% | 0.01% | -33.3% |
| Q2 2023 | $104,895,739 | +16.6% | 6,535,560 | -43.6% | 0.01% | +125.0% |
| Q1 2023 | $89,957,940 | +12.1% | 11,592,518 | +179.4% | 0.00% | -50.0% |
| Q4 2022 | $80,276,301 | -7.1% | 4,148,646 | +2.3% | 0.01% | -11.1% |
| Q3 2022 | $86,440,000 | +58.2% | 4,056,341 | +1.0% | 0.01% | +80.0% |
| Q2 2022 | $54,648,000 | -42.0% | 4,015,351 | +0.1% | 0.01% | -37.5% |
| Q1 2022 | $94,243,000 | +12.1% | 4,012,030 | +27.6% | 0.01% | +33.3% |
| Q4 2021 | $84,040,000 | +59.9% | 3,145,202 | +0.2% | 0.01% | +50.0% |
| Q3 2021 | $52,571,000 | +36.6% | 3,139,402 | +0.5% | 0.00% | +33.3% |
| Q2 2021 | $38,475,000 | – | 3,122,512 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 5,450,000 | $74,719,500 | 8.73% |
| Kynam Capital Management, LP | 2,956,053 | $40,527,487 | 6.63% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 758,355 | $10,381,880 | 3.50% |
| Sofinnova Investments, Inc. | 3,467,156 | $47,534,709 | 3.00% |
| Altium Capital Management LP | 333,681 | $4,574,767 | 2.39% |
| Eversept Partners, LP | 1,478,489 | $20,270,084 | 1.72% |
| SECTORAL ASSET MANAGEMENT INC | 357,139 | $4,896,376 | 0.95% |
| Carlyle Group Inc. | 1,438,155 | $19,688,342 | 0.85% |
| Orbimed Advisors | 1,518,115 | $20,813,357 | 0.44% |
| Woodline Partners LP | 2,562,600 | $35,133,246 | 0.41% |